Bulletin – Page 10 – Recovery Research Institute

Hundreds of easy-to-read articles summarizing the latest evidence-based information and findings in addiction treatment and recovery research.

LEARN ABOUT THE RECOVERY BULLETIN STAFF

Aug 29, 2019

Buprenorphine, but not naltrexone or its extended release version Vivitrol, is associated with reduced overdose risk

Read More

Dec 28, 2020

Risk factors for gabapentin use among injection drug users

Read More

Oct 25, 2020

Does race influence likelihood that pregnant women with opioid use disorder receive medication?

Read More

Dec 8, 2022

Can pharmacists improve medication stability for individuals moving across levels of addiction care?

Read More

Feb 22, 2023

Recovery support and harm reduction strategies both critical to addressing the opioid crisis, new research shows

Read More

Researchers study text message treatment and suboxone for improving substance use disorder communication

Feb 22, 2017

Text Messaging Buprenorphine (Suboxone) Programs Improve Communication with Clinicians

Read More

This study investigates this problem further by comparing people with substance use disorder (SUD) to those who smoke cigarettes or are obese to see which condition is most highly stigmatized. It also investigates if public opinion differs based on having an active disorder or one that is in remission.

Feb 24, 2017

Substance Use More Stigmatized Than Smoking Cigarettes and Obesity

Read More

Oct 31, 2019

Integrating medications for opioid use disorder into a 12-step treatment program

Read More

Apr 24, 2023

Staff experiences with a legislative mandate to provide buprenorphine and methadone in correctional settings

Read More

Loading...